Young Adult Outcomes for Children With 22q11 Deletion Syndrome and Comorbid ADHD
- PMID: 29378061
- PMCID: PMC6251524
- DOI: 10.1093/jpepsy/jsy002
Young Adult Outcomes for Children With 22q11 Deletion Syndrome and Comorbid ADHD
Abstract
Background: 22q11.2 deletion syndrome (22q11DS) is a common microdeletion syndrome associated with a variety of negative health, cognitive, emotional, and behavioral outcomes. 22q11DS is comorbid with many psychiatric disorders including attention-deficit/hyperactivity disorder (ADHD). The current study aimed to investigate the cognitive, behavioral, and functional outcomes that a childhood ADHD diagnosis predicts to in adulthood.
Methods: This longitudinal study followed 52 individuals with 22q11DS over 9 years. Childhood ADHD was operationalized both categorically (Diagnostic and statistical manual - 4th edition (DSM-IV) ADHD diagnoses) and dimensionally (inattentive and hyperactive-impulsive symptoms) and was tested as predictors of young adult outcomes.
Results: As young adults, children with 22q11DS + baseline ADHD had more parent-reported executive dysfunction and lower levels of clinician-rated overall functioning than those with 22q11DS yet without ADHD. Dimensional symptoms of ADHD in childhood did not predict young adult outcomes. No self-report differences emerged between those with and without baseline ADHD. The majority (82.4%) of individuals with 22q11DS + baseline ADHD were never treated with an ADHD medication.
Conclusions: A categorical diagnosis of ADHD in childhood predicted a greater variety of worse outcomes than dimensional levels of ADHD symptoms. Despite the significant impact of comorbid ADHD in 22q11DS, evidence-based treatment rates were low.
Similar articles
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.Psychol Med. 2019 Aug;49(11):1914-1922. doi: 10.1017/S0033291718002696. Epub 2018 Sep 18. Psychol Med. 2019. PMID: 30226117
-
Childhood Executive Functioning Predicts Young Adult Outcomes in 22q11.2 Deletion Syndrome.J Int Neuropsychol Soc. 2018 Oct;24(9):905-916. doi: 10.1017/S1355617718000784. J Int Neuropsychol Soc. 2018. PMID: 30375321 Free PMC article.
-
Special considerations in diagnosing and treating attention-deficit/hyperactivity disorder.CNS Spectr. 2007 Jun;12(6 Suppl 9):1-14; quiz 15-6. doi: 10.1017/s1092852900026092. CNS Spectr. 2007. PMID: 17545959 Review.
-
[Awareness of adult attention-deficit/hyperactivity disorder (ADHD) in Greece].Psychiatriki. 2012 Jun;23 Suppl 1:60-5. Psychiatriki. 2012. PMID: 22796974 Review. Greek, Modern.
Cited by
-
Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial.Int J Neuropsychopharmacol. 2022 Mar 17;25(3):215-225. doi: 10.1093/ijnp/pyab057. Int J Neuropsychopharmacol. 2022. PMID: 34453525 Free PMC article. Clinical Trial.
-
Neurological Complications in Inborn Errors of Immunity: A Scoping Review of Clinical Spectrum, Pathophysiological Mechanisms, and Therapeutic Strategies.Clin Rev Allergy Immunol. 2025 Jul 18;68(1):67. doi: 10.1007/s12016-025-09078-7. Clin Rev Allergy Immunol. 2025. PMID: 40681725
-
Genotypic and phenotypic variability of 22q11.2 microdeletions - an institutional experience.AIMS Mol Sci. 2021;8(4):257-274. doi: 10.3934/molsci.2021020. Epub 2021 Dec 9. AIMS Mol Sci. 2021. PMID: 34938854 Free PMC article.
References
-
- Achenbach T. M., Rescorla L. A. (2003). Manual for the ASEBA adult forms and profiles. Burlington, VT: University of Vermont.
-
- Antshel K. M., Phillips M. H., Gordon M., Barkley R., Faraone S. V. (2006). Is ADHD a valid disorder in children with intellectual delays? Clinical Psychology Review, 26, 555–572. - PubMed
-
- APA. (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (4th ed.). Washington, DC: American Psychiatric Association.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials